Free Trial

InMode (INMD) Competitors

InMode logo
$18.90 -0.07 (-0.37%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$18.90 0.00 (-0.03%)
As of 02/21/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

INMD vs. NARI, NVST, PRCT, IRTC, WRBY, LIVN, ENOV, NVCR, TMDX, and LMAT

Should you be buying InMode stock or one of its competitors? The main competitors of InMode include Inari Medical (NARI), Envista (NVST), PROCEPT BioRobotics (PRCT), iRhythm Technologies (IRTC), Warby Parker (WRBY), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), TransMedics Group (TMDX), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry.

InMode vs.

InMode (NASDAQ:INMD) and Inari Medical (NASDAQ:NARI) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations, valuation and community ranking.

InMode received 96 more outperform votes than Inari Medical when rated by MarketBeat users. Likewise, 73.64% of users gave InMode an outperform vote while only 57.89% of users gave Inari Medical an outperform vote.

CompanyUnderperformOutperform
InModeOutperform Votes
162
73.64%
Underperform Votes
58
26.36%
Inari MedicalOutperform Votes
66
57.89%
Underperform Votes
48
42.11%

68.0% of InMode shares are held by institutional investors. Comparatively, 91.0% of Inari Medical shares are held by institutional investors. 6.9% of InMode shares are held by insiders. Comparatively, 10.6% of Inari Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

InMode has a net margin of 45.91% compared to Inari Medical's net margin of -13.68%. InMode's return on equity of 18.25% beat Inari Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
InMode45.91% 18.25% 16.33%
Inari Medical -13.68%-10.09%-6.60%

InMode presently has a consensus target price of $22.25, suggesting a potential upside of 17.72%. Inari Medical has a consensus target price of $68.00, suggesting a potential downside of 14.97%. Given InMode's stronger consensus rating and higher probable upside, analysts clearly believe InMode is more favorable than Inari Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InMode
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40
Inari Medical
0 Sell rating(s)
12 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.14

In the previous week, Inari Medical had 3 more articles in the media than InMode. MarketBeat recorded 8 mentions for Inari Medical and 5 mentions for InMode. InMode's average media sentiment score of 1.63 beat Inari Medical's score of 0.54 indicating that InMode is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
InMode
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Inari Medical
3 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

InMode has a beta of 2.13, indicating that its share price is 113% more volatile than the S&P 500. Comparatively, Inari Medical has a beta of 1.02, indicating that its share price is 2% more volatile than the S&P 500.

InMode has higher earnings, but lower revenue than Inari Medical. Inari Medical is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InMode$394.82M3.33$181.27M$2.358.04
Inari Medical$574.50M8.15-$1.64M-$1.35-59.24

Summary

InMode beats Inari Medical on 12 of the 17 factors compared between the two stocks.

Get InMode News Delivered to You Automatically

Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INMD vs. The Competition

MetricInModeElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$1.31B$3.41B$5.80B$8.95B
Dividend YieldN/A1.65%4.78%3.85%
P/E Ratio8.0415.9826.4518.81
Price / Sales3.3374.99450.0676.66
Price / Cash10.6345.9944.0437.47
Price / Book1.873.867.634.64
Net Income$181.27M$92.00M$3.18B$245.69M
7 Day Performance0.48%4.49%-1.85%-2.63%
1 Month Performance11.44%7.92%0.19%-2.37%
1 Year Performance-9.31%13.43%17.21%13.64%

InMode Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INMD
InMode
2.0758 of 5 stars
$18.90
-0.4%
$22.25
+17.7%
-9.3%$1.31B$394.82M8.04480Positive News
NARI
Inari Medical
1.6761 of 5 stars
$79.93
flat
$68.00
-14.9%
+40.0%$4.68B$493.63M-59.211,300
NVST
Envista
3.544 of 5 stars
$21.59
+0.3%
$20.21
-6.4%
-6.5%$3.71B$2.51B-3.3312,800
PRCT
PROCEPT BioRobotics
3.2668 of 5 stars
$67.61
-2.4%
$97.86
+44.7%
+28.3%$3.53B$199.84M-34.67430Positive News
IRTC
iRhythm Technologies
1.1354 of 5 stars
$112.11
-0.1%
$108.45
-3.3%
+6.8%$3.51B$492.68M-23.072,000Earnings Report
Analyst Forecast
News Coverage
Gap Up
WRBY
Warby Parker
2.5425 of 5 stars
$25.70
-2.7%
$21.77
-15.3%
+71.6%$2.61B$669.77M-95.193,491Upcoming Earnings
Analyst Forecast
LIVN
LivaNova
3.5803 of 5 stars
$47.68
+0.1%
$69.17
+45.1%
-16.5%$2.59B$1.15B113.522,900Upcoming Earnings
ENOV
Enovis
3.4615 of 5 stars
$43.89
+0.4%
$64.83
+47.7%
-29.1%$2.50B$1.71B-20.046,550Short Interest ↓
Positive News
NVCR
NovoCure
3.4804 of 5 stars
$22.48
+3.5%
$32.67
+45.3%
+41.4%$2.43B$509.34M-16.061,453Upcoming Earnings
News Coverage
TMDX
TransMedics Group
3.6152 of 5 stars
$72.18
+1.3%
$122.70
+70.0%
-17.3%$2.42B$241.62M76.79210News Coverage
Gap Up
LMAT
LeMaitre Vascular
1.9524 of 5 stars
$98.65
+1.7%
$94.63
-4.1%
+59.9%$2.22B$193.48M53.91490

Related Companies and Tools


This page (NASDAQ:INMD) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners